Gene · 8243
Papers2,883
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,883
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Naegleria genus pangenome reveals new structural and functional insights into the versatility of these free-living amoebae. | Front Microbiol | 2022 | 36817109 | PubTator, text mining | PubMed |
| Comparative analysis of thoracic and abdominal aortic aneurysms across the segment and species at the single-cell level. | Front Pharmacol | 2022 | 36703732 | PubTator, text mining | PubMed |
| DeteX: A highly accurate software for detecting SNV and InDel in single and paired NGS data in cancer research. | Front Genet | 2022 | 36685970 | PubTator, text mining | PubMed |
| Concurrent Mutations in SF3B1 and PHF6 in Myeloid Neoplasms. | Biology (Basel) | 2022 | 36671709 | PubTator, text mining | PubMed |
| Bioinformatics analysis of the prognostic biomarkers and predictive accuracy of differentially expressed genes in high-risk multiple myeloma based on Gene Expression Omnibus database mining. | Ann Transl Med | 2022 | 36660705 | PubTator, text mining | PubMed |
| Epimutations and Their Effect on Chromatin Organization: Exciting Avenues for Cancer Treatment. | Cancers (Basel) | 2022 | 36612210 | PubTator, text mining | PubMed |
| Protein acylation: mechanisms, biological functions and therapeutic targets. | Signal Transduct Target Ther | 2022 | 36577755 | PubTator, text mining | PubMed |
| Case report: Chronic neutrophilic leukemia associated with monoclonal gammopathies. A case series and review of genetic characteristics and practical management. | Front Oncol | 2022 | 36568246 | PubTator, text mining | PubMed |
| ncRNA-mediated overexpression of ubiquitin-specific proteinase 13 contributes to the progression of prostate cancer via modulating AR signaling, DNA damage repair and immune infiltration. | BMC Cancer | 2022 | 36564767 | PubTator, text mining | PubMed |
| ACTR5 controls CDKN2A and tumor progression in an INO80-independent manner. | Sci Adv | 2022 | 36563143 | PubTator, text mining | PubMed |
| Contingent Synergistic Interactions between Non-Coding RNAs and DNA-Modifying Enzymes in Myelodysplastic Syndromes. | Int J Mol Sci | 2022 | 36555712 | PubTator, text mining | PubMed |
| Enteric Neuromyopathies: Highlights on Genetic Mechanisms Underlying Chronic Intestinal Pseudo-Obstruction. | Biomolecules | 2022 | 36551277 | PubTator, text mining | PubMed |
| Chronic alcohol-induced dysbiosis of the gut microbiota and gut metabolites impairs sperm quality in mice. | Front Microbiol | 2022 | 36532416 | PubTator, text mining | PubMed |
| Combined proteomics and single cell RNA-sequencing analysis to identify biomarkers of disease diagnosis and disease exacerbation for systemic lupus erythematosus. | Front Immunol | 2022 | 36524113 | PubTator, text mining | PubMed |
| Case report: A novel heterozygous synonymous variant in deep exon region of NIPBL gene generating a non-canonical splice donor in a patient with cornelia de lange syndrome. | Front Genet | 2022 | 36506332 | PubTator, text mining | PubMed |
| Placental Transcriptome Profiling in Subtypes of Diabetic Pregnancies Is Strongly Confounded by Fetal Sex. | Int J Mol Sci | 2022 | 36499721 | PubTator, text mining | PubMed |
| An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies. | Cell Mol Life Sci | 2022 | 36494469 | PubTator, text mining | PubMed |
| A cohesin traffic pattern genetically linked to gene regulation. | Nat Struct Mol Biol | 2022 | 36482254 | PubTator, text mining | PubMed |
| LncRNAs-associated to genomic instability: A barrier to cancer therapy effectiveness. | Front Genet | 2022 | 36479250 | PubTator, text mining | PubMed |
| Enhancer-promoter interactions and transcription are largely maintained upon acute loss of CTCF, cohesin, WAPL or YY1. | Nat Genet | 2022 | 36471071 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8243/papers?page=19